COVID-19-associated Invasive Fungal Infection – OFID publication

Published as an editor’s choice article in Open Forum Infectious Diseases on November 16, 2021, COVID-19-associated Invasive Fungal Infection was written by faculty members of the COVID-19-associated Fungal Infections Educational Initiative as well as a medical epidemiologist from the Center for Disease Control and Prevention (Brendan Jackson, MD, MPH). Under the leadership of John W. Baddley, MD, and George R. Thompson, III, MD, the authors addressed a range of salient topics, including:

  • Pathophysiology of COVID-19 as it relates to the risk of invasive fungal infections (IFIs)
  • COVID-19—associated pulmonary aspergillosis (CAPA) incidence, mortality, pathophysiology, risk factors, diagnosis, definitions, and management
  • Key updates on various aspects of other IFIs associated with COVID-19:
    • Non-Aspergillus mold infections, including mucormycosis
    • Candidiasis
    • Pneumocystosis
    • Endemic mycoses
    • Cryptococcosis
Click here for Free-Access